Member Info for Dr_Horrible

I'll pop over and have a word with them.

Hurry up SAMR approval for the sake of ByHealth, Provexis and us.

That’s my assumption too.

Not sure if it has FF or not. It suggests it does, but clearly not listed as an ingredient. I don’t believe the daily sales or remaining sale time or the reviews. The reviews just seem to have pictures of legs, none of which seem to be particularly suffering from oedema. There is no company info or about us page and the privacy page is a template that has not been changed.

Yeh, oddly mentions it on the page, but not on the ingredients.

I saw LegPill a couple of weeks back. It came up on FF search, but couldn’t see that it contained it.

Gix, what I was thinking is that they are already probably applying for BlueCap on the existing Blood Pressure claim. No reason for us to know about that.

I assume that BH will have applied for a health claim that FF ‘aids in maintaining healthy blood pressure’. As the evidence is based on 300mg, it would separate it from the platelet claim.

I was only saying to the wife the other day that I wish I could find more information on the cardioprotective effects of Fruitflow® against Doxorubicin-induced toxicity in rat cardiomyoblast cells H9c2 (2-1) and high-fat diet-induced dyslipidemia and pathological alteration in cardiac tissue of Wistar Albino rats.

I emailed them yesterday with a link to the required info on it too.

Rich in beneficial compounds, particularly lycopene.

Https://medicaldialogues.in/diet-nutrition/news/water-soluble-tomato-concentrate-could-improve-heart-health-in-older-adults-with-high-cholesterol-finds-study-135809

Sphinx, what makes you say that? I’ve not read it all yet, busy at work.

13 months today

My final guess for the end of year results.

FF sales = £1.15m, FF+ sales = £163k

Sales since April;

FF sales = £780k, FF+ sales = £84k

And “ The Company has previously announced it has been working with By-Health to support the planned launch of a number of Fruitflow based products in the Chinese market, with potential volumes at a significant multiple of current Fruitflow sales.”

BB, this implies that substantial multiples is part of the DSM/PXS relationship.

"An increasing number of commercial projects have been initiated by DSM with prospective customers in recent years, including some prospective customers which are part of global businesses, and the total projected annual sales value of the prospective sales pipeline for Fruitflow, which is now shared across Provexis and DSM, continues to stand at a substantial multiple of existing annual sales.". So I work on the assumption that BH is on top of that.

"Patent pending" (sometimes abbreviated by "pat. pend." or "pat. pending") or "patent applied for" are legal designations or expressions that can be used in relation to a product or process once a patent application for the product or process has been filed, but prior to the patent being issued or the application abandoned. The marking serves to notify the public, business, or potential infringers who would copy the invention that they may be liable for damages (including back-dated royalties), seizure, and injunction once a patent is issued.

A good question to ask at the AGM "Why has the prospective sales pipeline being reported as substantial multiples of current FF sales for 6 years, but that has never been realised in that time. Why is the sales pipeline so big, but never realised? What are the main barriers?, is there a timeline for when we can expect to see a more rapid growth?".

BB, its also a meaningless measure because they have being saying it since around 2018. 6 years later and we have not seen a big shift in revenue. That proves it is nonsense. 6 years is a long time for them to keep giving the same statement without any results.